Create Free Account

By creating account you will get access to hot stocks & personalised emails

Veeva Systems Inc Class A

Healthcare US VEEV

219.52USD
-2.02(0.91%)

Last update at 2024-12-19T18:54:00Z

Day Range

218.11226.95
LowHigh

52 Week Range

157.00225.49
LowHigh

Fundamentals

  • Previous Close 221.54
  • Market Cap30602.70M
  • Volume451353
  • P/E Ratio54.61
  • Dividend Yield-%
  • EBITDA434.67M
  • Revenue TTM2296.44M
  • Revenue Per Share TTM14.40
  • Gross Profit TTM 1545.65M
  • Diluted EPS TTM3.48

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Income before tax 509.10M 512.31M 393.99M 313.70M 238.64M
Minority interest - - - - -
Net income 487.71M 427.39M 380.00M 301.12M 229.83M
Selling general administrative 217.59M 171.51M 149.11M 114.27M 86.41M
Selling and marketing expenses 348.69M 288.06M 235.01M 190.33M 148.87M
Gross profit 1545.65M 1347.10M 1056.14M 800.71M 616.93M
Reconciled depreciation 29.12M 27.45M 29.45M 19.86M 14.07M
Ebit 459.09M 505.50M 377.79M 286.22M 222.87M
Ebitda 488.21M 532.94M 407.25M 314.04M 236.94M
Depreciation and amortization 29.12M 27.45M 29.45M 27.82M 14.07M
Non operating income net other - - 16.20M 27.48M 15.78M
Operating income 459.09M 505.50M 377.79M 286.22M 222.87M
Other operating expenses 1695.97M 1345.28M 1087.28M 817.86M 639.34M
Interest expense -50.00500M 14.73M 16.20M 27.48M 0.00000M
Tax provision 21.39M 84.92M 13.99M 12.58M 8.81M
Interest income 45.86M 14.73M 15.86M 25.18M 15.39M
Net interest income 45.86M 14.73M 15.86M 25.18M 15.39M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 21.39M 84.92M 13.99M 12.58M 8.81M
Total revenue 2155.06M 1850.78M 1465.07M 1104.08M 862.21M
Total operating expenses 1086.56M 841.60M 678.35M 514.49M 394.06M
Cost of revenue 609.40M 503.68M 408.93M 303.37M 245.28M
Total other income expense net 50.01M 6.82M 16.20M 27.48M 15.78M
Discontinued operations - - - - -
Net income from continuing ops 487.71M 427.39M 380.00M 301.12M 229.83M
Net income applicable to common shares 487.71M 427.39M 380.00M 301.12M 229.83M
Preferred stock and other adjustments - - - - -
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Total assets 4804.30M 3816.47M 3046.07M 2271.78M 1653.77M
Intangible assets 82.48M 101.94M 114.59M 134.60M 24.52M
Earning assets - - - - -
Other current assets 81.46M 36.68M 35.61M 21.87M 21.67M
Total liab 1088.04M 904.83M 779.75M 606.18M 416.02M
Total stockholder equity 3716.25M 2911.64M 2266.32M 1665.59M 1237.75M
Deferred long term liab 31.82M 33.11M 42.07M 2.42M 30.87M
Other current liab 84.53M 77.70M 63.98M 52.85M 28.66M
Common stock 0.00200M 0.00200M 0.00200M 0.00100M 0.00100M
Capital stock 0.00200M 0.00200M 0.00200M 0.00100M 0.00100M
Retained earnings 2214.75M 1727.05M 1299.66M 919.66M 619.20M
Other liab 31.57M 20.44M 12.40M 10.20M 14.99M
Good will 439.88M 439.88M 436.03M 438.53M 95.80M
Other assets 207.48M 63.33M 74.05M 63.64M 45.06M
Cash 886.47M 1138.04M 730.50M 476.73M 550.97M
Cash and equivalents - - - - -
Total current liabilities 1006.80M 840.78M 715.95M 551.17M 401.02M
Current deferred revenue 869.28M 731.75M 616.99M 468.89M 356.36M
Net debt -825.48900M -1083.45200M -667.38600M -421.90500M -550.97100M
Short term debt 11.31M 10.98M 11.72M 10.01M 6.89M
Short long term debt - - - - -
Short long term debt total 60.98M 54.59M 63.12M 54.83M -
Other stockholder equity 1532.63M 1196.55M 965.67M 745.48M 617.62M
Property plant equipment 105.15M 104.14M 110.57M 54.75M 54.97M
Total current assets 3969.31M 3107.18M 2310.83M 1531.12M 1433.41M
Long term investments - - - - -
Net tangible assets 3193.90M 2369.82M 1715.70M 1092.46M 1117.42M
Short term investments 2216.16M 1238.06M 933.12M 610.01M 539.19M
Net receivables 785.23M 694.40M 611.59M 422.51M 321.59M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 41.68M 20.35M 23.25M 19.42M 9.11M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -31.12900M -11.95800M 0.99M 0.46M 0.93M
Additional paid in capital - - - - -
Common stock total equity - - 0.00200M 0.00100M 0.00100M
Preferred stock total equity - - - - -
Retained earnings total equity - - 1299.66M 919.66M 619.20M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 70.78M 58.23M 17.88M 16.18M 8.25M
Deferred long term asset charges - - 42.07M 35.59M 36.81M
Non current assets total 834.98M 709.28M 735.24M 740.65M 220.35M
Capital lease obligations 60.98M 54.59M 63.12M 54.83M -
Long term debt total - - - 0.36M -
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Investments -1007.68300M -324.15800M -333.63400M -64.42700M -94.05000M
Change to liabilities 161.90M 113.15M 148.23M -10.43200M 95.89M
Total cashflows from investing activities -1007.68300M -346.15200M -333.63400M -516.91000M -103.86900M
Net borrowings - -0.38400M -1.03900M -0.98400M -0.98400M
Total cash from financing activities -19.37600M -4.14000M 33.82M 10.01M 25.91M
Change to operating activities -60.66100M -14.68100M -32.40200M -49.79300M -25.48400M
Net income 487.71M 427.39M 380.00M 301.12M 229.83M
Change in cash -251.57500M 409.51M 251.91M -72.38100M 230.79M
Begin period cash flow 1141.22M 731.71M 479.80M 552.18M 321.39M
End period cash flow 889.65M 1141.22M 731.71M 479.80M 552.18M
Total cash from operating activities 780.47M 764.46M 551.25M 437.38M 310.83M
Issuance of capital stock - - - - -
Depreciation 29.12M 27.45M 29.45M 27.82M 14.07M
Other cashflows from investing activities - - -8.68300M -449.37000M -1.37900M
Dividends paid - - - - -
Change to inventory - - -22.64800M -37.98000M -10.68000M
Change to account receivables -72.17700M -67.02000M -174.06700M -55.53100M -78.99500M
Sale purchase of stock - - 34.86M 10.99M 25.91M
Other cashflows from financing activities -19.37600M -3.75600M 34.86M 10.99M 25.91M
Change to netincome 234.21M 262.91M 196.76M 109.37M 68.36M
Capital expenditures 2.49M 2.49M 0.57M 4.32M 9.82M
Change receivables - - -174.06700M -55.53100M -78.99500M
Cash flows other operating - - -32.08000M 55.75M -34.27700M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 251.43M -69.52500M 232.87M
Change in working capital 7.34M 20.66M -75.64600M -18.18200M -17.37800M
Stock based compensation 351.91M 234.64M 185.00M 115.91M 76.42M
Other non cash items 31.90M 43.25M 33.49M 17.37M 15.97M
Free cash flow 777.98M 761.97M 551.81M 433.05M 301.01M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VEEV
Veeva Systems Inc Class A		 -2.02 0.91% 219.52 54.61 33.22 12.83 6.73 11.14 58.84
GEHC
GE HealthCare Technologies Inc.		 0.62 0.80% 77.71 22.91 20.12 2.01 5.52 2.39 13.30
MTHRF
M3 Inc		 - -% 9.73 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.13 2.97% 4.25 31.84 26.25 0.05 4.60 0.04 0.12
HQY
HealthEquity Inc		 3.08 3.36% 94.62 123.86 42.37 6.88 3.38 7.41 26.13

Reports Covered

Stock Research & News

View All

Profile

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Veeva Systems Inc Class A

4280 Hacienda Drive, Pleasanton, CA, United States, 94588

Key Executives

Name Title Year Born
Mr. Peter P. Gassner Founder, CEO & Director 1965
Mr. Thomas D. Schwenger Pres & COO 1968
Mr. Brent R. Bowman Chief Financial Officer 1967
Mr. Alan V. Mateo Exec. VP of Global Sales 1962
Ms. Michele O'Connor Chief Accounting Officer 1977
Mr. Pinal Patel Chief Information Officer NA
Mr. Ato Garrett Sr. Director of Investor Relations NA
Mr. Jonathan W. Faddis Sr. VP, Gen. Counsel & Corp. Sec. 1972
Mr. Jacques Mourrain Ph.D. VP of Quality & Compliance NA
Ms. Eleni Nitsa Zuppas Chief Marketing Officer 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.